Metraipolis › archive › dc_6b41a003142b
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB — Europe PMC PMID:40821684
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40821684
- DOI
- 10.5588/ijtldopen.25.0151
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T16:17:06.853Z
- SHA-256 of the archived text
c623c4110c1e25b2eec23bc59fe5d1955ff5ff2a2fb211470635c3db94c19bc7- Stable URL of this page
https://metraipolis.com/documento/dc_6b41a003142b
How to cite
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB — Europe PMC PMID:40821684 — Europe PMC (en), https://europepmc.org/article/MED/40821684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b41a003142b (Metraipolis archive dc_6b41a003142b, sha256 c623c4110c1e25b2eec23bc59fe5d1955ff5ff2a2fb211470635c3db94c19bc7)
BibTeX
@misc{dc6b41a003142b,
title = {Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB — Europe PMC PMID:40821684},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40821684},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b41a003142b; sha256 c623c4110c1e25b2eec23bc59fe5d1955ff5ff2a2fb211470635c3db94c19bc7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40821684. Agents can read the archived copy with the MCP tool read_document.